BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang J, Lin Y, Lin Z, Wei Q, Qian J, Ruan R, Jiang X, Hou L, Song J, Ding J, Yang H. Stimuli-Responsive Nanoparticles for Controlled Drug Delivery in Synergistic Cancer Immunotherapy. Adv Sci (Weinh) 2022;9:e2103444. [PMID: 34927373 DOI: 10.1002/advs.202103444] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Singh N, Handa M, Singh V, Kesharwani P, Shukla R. Lymphatic targeting for therapeutic application using nanoparticulate systems. J Drug Target 2022;:1-34. [PMID: 35722764 DOI: 10.1080/1061186X.2022.2092741] [Reference Citation Analysis]
2 Alhaj-suliman SO, Wafa EI, Salem AK. Engineering nanosystems to overcome barriers to cancer diagnosis and treatment. Advanced Drug Delivery Reviews 2022. [DOI: 10.1016/j.addr.2022.114482] [Reference Citation Analysis]
3 Zhang Z, Gao A, Sun C. Tumor pH-Responsive Nanocarriers With Light-Activatable Drug Release for Chemo-Photodynamic Therapy of Breast Cancer. Front Chem 2022;10:905645. [DOI: 10.3389/fchem.2022.905645] [Reference Citation Analysis]
4 Caers J, Duray E, Vrancken L, Marcion G, Bocuzzi V, De Veirman K, Krasniqi A, Lejeune M, Withofs N, Devoogdt N, Dumoulin M, Karlström AE, D’huyvetter M. Radiotheranostic Agents in Hematological Malignancies. Front Immunol 2022;13:911080. [DOI: 10.3389/fimmu.2022.911080] [Reference Citation Analysis]
5 Deng K, Yang D, Zhou Y. Nanotechnology-Based siRNA Delivery Systems to Overcome Tumor Immune Evasion in Cancer Immunotherapy. Pharmaceutics 2022;14:1344. [DOI: 10.3390/pharmaceutics14071344] [Reference Citation Analysis]
6 Xu W, Ye C, Qing X, Liu S, Lv X, Wang W, Dong X, Zhang Y. Multi-target tyrosine kinase inhibitor nanoparticle delivery systems for cancer therapy. Mater Today Bio 2022;16:100358. [PMID: 35880099 DOI: 10.1016/j.mtbio.2022.100358] [Reference Citation Analysis]
7 Niu Y, Lu Y. Construction of pH ‐responsive core crosslinked micelles via thiol‐yne click reaction. J of Applied Polymer Sci. [DOI: 10.1002/app.52753] [Reference Citation Analysis]
8 Chen H, Cheng H, Liang X, Cai S, Liu G. Immunosuppression Reversal Nanovaccines Substituting Dendritic Cells for Personalized Cancer Immunotherapy. Front Immunol 2022;13:934259. [DOI: 10.3389/fimmu.2022.934259] [Reference Citation Analysis]
9 He M, Wang R, Wan P, Wang H, Cheng Y, Miao P, Wei Z, Leng X, Li Y, Du J, Fan J, Sun W, Peng X. Biodegradable Ru-Containing Polycarbonate Micelles for Photoinduced Anticancer Multitherapeutic Agent Delivery and Phototherapy Enhancement. Biomacromolecules 2022. [PMID: 35107271 DOI: 10.1021/acs.biomac.1c01651] [Reference Citation Analysis]